Optimization of Diagnosis-Related Groups for 14,246 Patients with Uterine Leiomyoma in a Single Center in Western China Using a Machine Learning Model
Yuan Ma,Li Li,Li Yu,Wei He,Ling Yi,Yuxin Tang,Jijie Li,Zhigang Zhong,Meixian Wang,Shiyao Huang,Yiquan Xiong,Pei Xiao,Yuxiang Huang
DOI: https://doi.org/10.2147/rmhp.s442502
2024-03-02
Risk Management and Healthcare Policy
Abstract:Yuan Ma, 1, 2 Li Li, 1 Li Yu, 1 Wei He, 1 Ling Yi, 1 Yuxin Tang, 1 Jijie Li, 1 Zhigang Zhong, 3 Meixian Wang, 4 Shiyao Huang, 5, 6 Yiquan Xiong, 5, 6 Pei Xiao, 7 Yuxiang Huang 1 1 Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 2 Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, People's Republic of China; 3 Department of Prevention, Office of Cancer Prevention and Treatment, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China; 4 National Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 5 Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 6 NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, Sichuan, People's Republic of China; 7 Medical Insurance Office, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China Correspondence: Yuxiang Huang, Email Background: Uterine leiomyoma (UL) is one of the most common benign tumors in women, and its incidence is gradually increasing in China. The clinical complications of UL have a negative impact on women's health, and the cost of treatment poses a significant burden on patients. Diagnosis-related groups (DRG) are internationally recognized as advanced healthcare payment management methods that can effectively reduce costs. However, there are variations in the design and grouping rules of DRG policies across different regions. Therefore, this study aims to analyze the factors influencing the hospitalization costs of patients with UL and optimize the design of DRG grouping schemes to provide insights for the development of localized DRG grouping policies. Methods: The Mann–Whitney U -test or the Kruskal–Wallis H -test was employed for univariate analysis, and multiple stepwise linear regression analysis was utilized to identify the primary influencing factors of hospitalization costs for UL. Case combination classification was conducted using the exhaustive chi-square automatic interactive detection (E-CHAID) algorithm within a decision tree framework. Results: Age, occupation, number of hospitalizations, type of medical insurance, Transfer to other departments, length of stay (LOS), type of UL, admission condition, comorbidities and complications, type of primary procedure, other types of surgical procedures, and discharge method had a significant impact on hospitalization costs (P< 0.05). Among them, the type of primary procedure, other types of surgical procedures, and LOS were the main factors influencing hospitalization costs. By incorporating the type of primary procedure, other types of surgical procedures, and LOS into the decision tree model, patients were divided into 11 DRG combinations. Conclusion: Hospitalization costs for UL are mainly related to the type of primary procedure, other types of surgical procedures, and LOS. The DRG case combinations of UL based on E-CHAID algorithm are scientific and reasonable. Keywords: uterine leiomyoma, diagnosis-related groups, decision tree Uterine leiomyoma (UL), also known as uterine fibroids, is the most common benign pelvic tumor in women. 1,2 It originates from the smooth muscle cells in the myometrium and is characterized by the presence of an abundant extracellular matrix composed of collagen, fibronectin, and proteoglycans. 3,4 UL is most frequently diagnosed in women between the ages of 30 and 50, with the highest incidence observed in women aged 40 to 50, accounting for approximately 51.2% to 60.9% of cases. 5 Despite being a benign tumor, UL often presents with debilitating symptoms such as heavy menstrual bleeding, pelvic pressure, pain, and anemia. 6 Additionally, UL is associated with infertility, recurrent miscarriage, and preterm birth. 7 It is worth noting that approximately 70% of uterine sarcomas can be traced back to UL, and it also contributes to a significant proportion of uterine cancer-related deaths. 8 Consequently, the clinical complications of UL have a profound negative impact on women's health. The diagnosis of UL is established through four cl -Abstract Truncated-
health care sciences & services,health policy & services